Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-09-13 / Int. J. Cancer 2017 12;141(12):2505-2516https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-09-13 / Int. J. Cancer 2017 12;141(12):2505-25162017-09-13 00:00:002017-09-13 00:00:00Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-09-08 / Front Oncol 2017;7:195https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-09-08 / Front Oncol 2017;7:1952017-09-08 00:00:002019-02-15 09:23:13Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-09-01 / G Chir 2017 Sep-Oct;37(5):225-235https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-09-01 / G Chir 2017 Sep-Oct;37(5):225-2352017-09-01 00:00:002019-02-15 08:51:59Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-08-24 / Front Oncol 2017;7:179https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-08-24 / Front Oncol 2017;7:1792017-08-24 00:00:002017-08-24 00:00:00Oncolytic Viral Therapy for Mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-08-14 / Cancer Cell 2017 08;32(2):253-267.e5https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e52017-08-14 00:00:002017-08-14 00:00:00Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-27 / J. Virol. 2017 08;91(16)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-27 / J. Virol. 2017 08;91(16)2017-07-27 00:00:002017-07-27 00:00:00Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-26 / Integr Cancer Ther 2018 06;17(2):558-561https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-5612017-07-26 00:00:002019-02-15 08:37:24Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-25 / Front Pharmacol 2017;8:495https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-25 / Front Pharmacol 2017;8:4952017-07-25 00:00:002019-02-15 08:32:55Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-19 / Int J Cancer 2017 11;141(9):1891-1900https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-19 / Int J Cancer 2017 11;141(9):1891-19002017-07-19 00:00:002021-11-15 20:03:02Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-1264https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-12642017-07-15 00:00:002019-02-15 09:23:07Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2017-07-10 11:44:412019-07-15 16:57:22IOZK Artikel im International Journal of Molecular Sciences von Prof. Schirrmacher über die Rolle des Newcastle Disease Virus im Rahmen der Tumorimpfung,
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-07-04 / Oncotarget 2017 Jul;8(27):44593-44604https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-07-04 / Oncotarget 2017 Jul;8(27):44593-446042017-07-04 00:00:002019-02-15 09:18:16The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002017-06-27 / Oncotarget 2017 Sep;8(40):67439-67456https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2017-06-27 / Oncotarget 2017 Sep;8(40):67439-674562017-06-27 00:00:002017-06-27 00:00:00Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
Genetically engineered oncolytic Newcastle disease virus mediates cytolysis of prostate cancer stem like cells
Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity
Hematologic neoplasms: Dendritic cells vaccines in motion
Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
Oncolytic Viral Therapy for Mesothelioma
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
Recent developments in immunotherapy of acute myeloid leukemia
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia
Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
IOZK article in the International Journal of Molecular Sciences by Prof. Schirrmacher on the role of the Newcastle Disease Virus in tumor vaccination,
The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein